Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 1 day agoThe agency will now take the committee’s advice under consideration as it decides whether to approve...
New breakthrough Alzheimer’s drug gets unanimous backing from FDA advisers
NY Post via Yahoo News· 1 day agoThe vote clears the way for a final FDA decision on the treatment, which initially had been expected...
A guide to safe US sunscreens – and the ingredients to avoid
The Guardian via Yahoo News· 52 minutes agoSunscreen use has aesthetic benefits too...sunscreen ingredients have been classified as safe and...
FDA panel backs new Alzheimer's drug, Apple unveils new AI and iOS features and Warner Bros....
The Yodel via Yahoo News· 1 day agoGet caught up on this morning’s news: A new Alzheimer’s drug, the ‘Practical Magic’ sequel and more...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 24 hours agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 1 day agoImage Source: Zacks Investment Research Approval of new drugs and label expansion of the existing...
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
USA TODAY via Yahoo News· 2 days ago"Donanemab...said. "But it could be part of an effective cocktail, and we've got to start somewhere." Last year, the FDA approved Eisai and Biogen's < ...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 5 hours agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Senators press FDA, Justice Department on illegal vape sales
Courthouse News Service· 2 hours agoSenators for months have lambasted the FDA over its enforcement of illegal tobacco products, arguing...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 5 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...